Skip to main content

Safety and tolerability of duloxetine in women with stress urinary incontinence

Buy Article:

$51.00 plus tax (Refund Policy)



The serotonin/noradrenaline uptake inhibitor duloxetine has been shown to be effective in the medical treatment of stress urinary incontinence (SUI) in women. Aim 

To review the safety and tolerability of duloxetine with SUI. Methods 

A systematic Medline search for the key word ‘duloxetine’ was performed, and abstracts from recent international gynaecological and urological meetings were also considered. Results 

Various unpleasant adverse effects exist, among which nausea is the most frequent, but is mild to moderate and transient in most cases. Dose escalation upon initiation of treatment improves the tolerability of duloxetine. The use of duloxetine appears safe as it lacks the cardiovascular adverse effects of older amine reuptake inhibitors. Conclusions 

Duloxetine has an acceptable safety profile. Dose escalation combined with patient counselling on the intensity and transient nature of adverse effects may help to further improve the benefit/tolerability ratio of duloxetine in the treatment of SUI.

Keywords: Adverse effect; duloxetine; nausea; stress urinary incontinence

Document Type: Research Article


Affiliations: 1: Urology 2: Obstetrics & Gynecology

Publication date: May 1, 2006


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more